For a complementary incretin-adjacent approach, the cagrilintide published research article covers an amylin/GLP-1 co-agonist line of investigation, and the tirzepatide published research article summarizes the dual GIP/GLP-1 agonist that preceded triple-agonist development
A six-month cynomolgus monkey study of two DAC-modified peptides concluded that they produced no evidence of immunogenic or immunotoxic effects but FDA notes that the data description is vague, that the absence of neutralising antibodies appears to apply only to the other compound in that study, and that no assessment of plasma GH or IGF-1 was provided for the CJC-1295 DAC-treated monkeys to demonstrate that pharmacological activity even persisted through the dosing period [11]
358 These lipid abnormalities contribute to the dyslipidemia pattern often observed in individuals with metabolic syndrome
Additionally, nauseaa common side effectmay further limit fluid intake and electrolyte balance, intensifying headache symptoms
Fibersol-2 is a digestion-resistant soluble dietary fiber that is well tolerated and designed to reach the large intestine, where it functions as a prebiotic by helping nourish beneficial gut bacteria
Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease